These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10744738)

  • 1. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription.
    Kitaura H; Shinshi M; Uchikoshi Y; Ono T; Iguchi-Ariga SM; Ariga H
    J Biol Chem; 2000 Apr; 275(14):10477-83. PubMed ID: 10744738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1.
    Coqueret O; Gascan H
    J Biol Chem; 2000 Jun; 275(25):18794-800. PubMed ID: 10764767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.
    Gartel AL; Ye X; Goufman E; Shianov P; Hay N; Najmabadi F; Tyner AL
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4510-5. PubMed ID: 11274368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional sites of human PCNA which interact with p21 (Cip1/Waf1), DNA polymerase delta and replication factor C.
    Oku T; Ikeda S; Sasaki H; Fukuda K; Morioka H; Ohtsuka E; Yoshikawa H; Tsurimoto T
    Genes Cells; 1998 Jun; 3(6):357-69. PubMed ID: 9734782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex.
    Chen U; Chen S; Saha P; Dutta A
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11597-602. PubMed ID: 8876181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
    Ono T; Kitaura H; Ugai H; Murata T; Yokoyama KK; Iguchi-Ariga SM; Ariga H
    J Biol Chem; 2000 Oct; 275(40):31145-54. PubMed ID: 10878006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo.
    Cooper MP; Balajee AS; Bohr VA
    Mol Biol Cell; 1999 Jul; 10(7):2119-29. PubMed ID: 10397753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation of proliferating cell nuclear antigen (PCNA)-dependent DNA replication through a conserved p21(Cip1)-like PCNA-binding motif present in the third subunit of human DNA polymerase delta.
    Ducoux M; Urbach S; Baldacci G; Hübscher U; Koundrioukoff S; Christensen J; Hughes P
    J Biol Chem; 2001 Dec; 276(52):49258-66. PubMed ID: 11595739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
    Weiss RH; Randour CJ
    Cell Signal; 2000 Jun; 12(6):413-8. PubMed ID: 10889470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
    Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1.
    Hermeking H; Funk JO; Reichert M; Ellwart JW; Eick D
    Oncogene; 1995 Oct; 11(7):1409-15. PubMed ID: 7478565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite regulation of myc and p21waf1 transcription by STAT3 proteins.
    Barré B; Avril S; Coqueret O
    J Biol Chem; 2003 Jan; 278(5):2990-6. PubMed ID: 12438313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
    Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
    Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate.
    Gazitt Y; Reddy SV; Alcantara O; Yang J; Boldt DH
    J Cell Physiol; 2001 Apr; 187(1):124-35. PubMed ID: 11241357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and antiestrogen regulation of cell cycle progression in breast cancer cells.
    Doisneau-Sixou SF; Sergio CM; Carroll JS; Hui R; Musgrove EA; Sutherland RL
    Endocr Relat Cancer; 2003 Jun; 10(2):179-86. PubMed ID: 12790780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53-independent induction of G1 arrest and p21WAF1/CIP1 expression by ascofuranone, an isoprenoid antibiotic, through downregulation of c-Myc.
    Jeong JH; Kang SS; Park KK; Chang HW; Magae J; Chang YC
    Mol Cancer Ther; 2010 Jul; 9(7):2102-13. PubMed ID: 20587660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest.
    Claassen GF; Hann SR
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9498-503. PubMed ID: 10920185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adenoviral E1A oncoproteins interfere with the growth-inhibiting effect of the cdk-inhibitor p21(CIP1/WAF1).
    Keblusek P; Dorsman JC; Teunisse AF; Teunissen H; van der Eb AJ; Zantema A
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():381-390. PubMed ID: 10073698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.